PubMed:32178765 / 1853-2054 JSONTXT

Annnotations TAB JSON ListView MergeView

    Inflammaging

    {"project":"Inflammaging","denotations":[{"id":"T14","span":{"begin":0,"end":201},"obj":"Sentence"},{"id":"T14","span":{"begin":0,"end":201},"obj":"Sentence"}],"text":"From Aug 28, 2017, to Aug 17, 2018, we screened 624 patients, of whom 381 were randomly assigned and treated with guselkumab every 4 weeks (n=128), guselkumab every 8 weeks (n=127), or placebo (n=126)."}

    yaoziqian_800_3

    {"project":"yaoziqian_800_3","denotations":[{"id":"T11","span":{"begin":114,"end":124},"obj":"CI"},{"id":"T12","span":{"begin":148,"end":158},"obj":"CI"},{"id":"T24","span":{"begin":185,"end":192},"obj":"CI"}],"text":"From Aug 28, 2017, to Aug 17, 2018, we screened 624 patients, of whom 381 were randomly assigned and treated with guselkumab every 4 weeks (n=128), guselkumab every 8 weeks (n=127), or placebo (n=126)."}

    Zierdiyeerkenaili_800_3

    {"project":"Zierdiyeerkenaili_800_3","denotations":[{"id":"T12","span":{"begin":114,"end":124},"obj":"CI"},{"id":"T13","span":{"begin":148,"end":158},"obj":"CI"},{"id":"T21","span":{"begin":185,"end":192},"obj":"CI"}],"text":"From Aug 28, 2017, to Aug 17, 2018, we screened 624 patients, of whom 381 were randomly assigned and treated with guselkumab every 4 weeks (n=128), guselkumab every 8 weeks (n=127), or placebo (n=126)."}